scholarly journals Optimal Delivery Strategy for Stem Cell Therapy in Patients with Ischemic Heart Disease

Author(s):  
Andrei Cismaru ◽  
Gabriel Cismaru
2016 ◽  
Vol 21 (6) ◽  
pp. 737-752 ◽  
Author(s):  
Peisen Huang ◽  
Xiaqiu Tian ◽  
Qing Li ◽  
Yuejin Yang

2006 ◽  
Vol 21 (4) ◽  
pp. 327-342 ◽  
Author(s):  
Julia N. E. Sunkomat ◽  
Mohamed A. Gaballa

2010 ◽  
Vol 13 (12) ◽  
pp. 1879-1897 ◽  
Author(s):  
Mohammad Nurulqadr Jameel ◽  
Jianyi Zhang

2018 ◽  
Vol 11 (1) ◽  
pp. 1-12 ◽  
Author(s):  
Hyunsuk Jeong ◽  
Hyeon Woo Yim ◽  
Hun-Jun Park ◽  
Youngseung Cho ◽  
Hanter Hong ◽  
...  

2009 ◽  
Vol 14 (1) ◽  
pp. 79-84 ◽  
Author(s):  
Damien J LaPar ◽  
Irving L Kron ◽  
Zequan Yang

2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Kai Zhu ◽  
Jun Li ◽  
Yulin Wang ◽  
Hao Lai ◽  
Chunsheng Wang

Stem cell therapy has attracted increasing attention as a promising treatment strategy for cardiac repair in ischemic heart disease. Nanoparticles (NPs), with their superior physical and chemical properties, have been widely utilized to assist stem cell therapy. With the help of NPs, stem cells can be genetically engineered for enhanced paracrine profile. To further understand the fate and behaviors of stem cells in ischemic myocardium, imaging NPs can label stem cells and be trackedin vivounder multiple modalities. Besides that, NPs can also be used to enhance stem cell retention in myocardium. These facts have raised efforts on the development of more intelligent and multifunctional NPs for cellular application. Herein, an overview of the applications of NPs-assisted stem cell therapy is given. Key issues and future prospects are also critically addressed.


Author(s):  
Atta Behfar ◽  
Jozef Bartunek ◽  
Andre Terzic

2006 ◽  
Vol 15 (1_suppl) ◽  
pp. 47-56 ◽  
Author(s):  
Christof Stamm ◽  
Andreas Liebold ◽  
Gustav Steinhoff ◽  
Dirk Strunk

Sign in / Sign up

Export Citation Format

Share Document